InsidersTradesSigma
Browse the complete record of transactions filed by Goldstein Michael H., Président, Ophtalmologie et Directeur Médical. Insider active across 2 companies, notably OCULAR THERAPEUTIX, INC. Cumulatively, 2 reports have been logged. The latest transaction was disclosed on 3 February 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Michael H. Goldstein is the President of Ophthalmology and Chief Medical Officer at Ocular Therapeutix, Inc. He oversees the company's clinical and research initiatives. With expertise in the healthcare sector, he plays a key role in developing new therapies and improving patient care.